Maud Brandely

Plus aucun poste en cours

72 ans

Health Technology

Process Industries

Consumer Services

Profil

Maud Brandely worked as the Director of Oncology Clinical Development at Pierre Fabre SA and as the Director of Taxotere Clinical Development at Rhone-Poulenc SA. From 2016 to 2024, Dr. Brandely served as the Chief Medical Officer & VP of Medical Affairs at Transgene SA. Dr. Brandely obtained a graduate and doctorate degree from Université Pierre et Marie Curie.

Anciens postes connus de Maud Brandely

Sociétés	Poste	Fin
TRANSGENE	Directeur Technique/Scientifique/R&D	10/09/2024
Pierre Fabre SA Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals	Corporate Officer/Principal	01/02/2016
Rhone-Poulenc SA Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals	Corporate Officer/Principal	-

Voir l'expérience en détail de Maud Brandely

Formation de Maud Brandely

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Maud Brandely

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Transgene SA Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer	Health Technology
Pierre Fabre SA Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals	Health Technology
Rhone-Poulenc SA Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals	Process Industries
Université Pierre et Marie Curie Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services